ATYR - aTyr Pharma Inc Qarzning balans kapitallashuviga nisbati

aTyr Pharma Inc (ATYR) grafik logotipi

aTyr Pharma, Inc. (ATYR) mahsulotni bozorga chiqarish uchun yirik hamkor qidirayotgan bir paytda, o'zining asosiy dori nomzodini mustaqil ravishda rivojlantirishga e'tibor qaratmoqda. Qarzning balans kapitalizatsiyasiga nisbati kapital tuzilmasidagi tebranishlarni aks ettiradi, bunda 0.21 eng so'nggi darajani ifodalaydi. tRNA sintetazalari bo'yicha patentlar va FDA ning qat'iy nazorati himoya aktivlari vazifasini o'taydi. Daromadning yo'qligi kompaniyani jalb qilingan investitsiyalarning sarf-xarajatlar darajasiga (burn rate) bog'liq qilib qo'ygan.

ATYR (aTyr Pharmaceuticals) Qarzning balans qiymatiga nisbati tarixi 06.06.2024dan 28.10.2026gacha
aTyr Pharma Inc asosiy tovari

aTyr Pharma (ATYR) kompaniyasining biznes modeli fibrotik kasalliklar terapiyasi bo'yicha patentlarning uzoq muddatli monetizatsiyasiga tayanadi. Qarzning kapitalga nisbatini tahlil qilish orqali investor umumiy majburiyatlarning aksiyadorlar kapitaliga nisbatini ko'radi. Ushbu metrika moliyaviy richagning darajasini va moliyalashtirish tuzilmasining barqarorligini belgilaydi. Ushbu ko'rsatkichning pasayishi dori vositalarini ishlab chiqishning uzoq davom etadigan sikli davomida defolt xatarlarini minimallashtiradi. Barqaror richag kompaniyaning ortiqcha qarz olmasdan prognoz qilingan marjalarni saqlab qolish qobiliyatini tasdiqlaydi.

aTyr Pharma, Inc. kimlar bilan raqobatlashadi

Balans kapitallashuviga qarzlar ARGX (argenx SE)|biontech.de - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati ABIVAX (ABVX)|ADMA: Qarzning sof aktivlarga nisbati|PTGX (Protagonist Therapeutics Inc) - Qarzning balans kapitallashuviga nisbati|Immunovant Therapeutics (IMVT) - Qarzning balans qiymatiga nisbati|KNSA (Kiniksa Pharmaceuticals) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar grifols.com (GRFS)|Adaptive Biotechnologies Corporation (ADPT) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Celldex Therapeutics Inc (CLDX)|Balans kapitallashuviga qarzlar AUPH|BioCryst Corp - Sof aktivlarga qarzlar|VERA: Qarzning balans kapitallashuviga nisbati|DNTH: Qarzning balans qiymatiga nisbati|PHVS (Pharvaris) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati AbCellera Bio|TRML (Tourmaline Corp) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar PGEN|Qarzning balans kapitallashuviga nisbati Pharming Group N.V. PHAR|Qarzning balans qiymatiga nisbati nektar.com (NKTR)|UPB: Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Zenas Bio ZBIO|Immunome Corp - Balans kapitallashuviga qarzlar|Gossamer Bio Corp. (GOSS) - Balans kapitallashuviga qarzlar|KALV - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati septerna.com|Qarzning balans qiymatiga nisbati PVLA (Pieris Pharmaceuticals, Inc.)|Balans qiymatiga qarzlar SVRA|Rigel Pharmaceuticals Inc (RIGL) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati AnaptysBio Inc. ANAB|Qarzning balans qiymatiga nisbati Astria Therapeutics|engene.com - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati RAPT Therapeutics, Inc.|JBIO - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar Aclaris ACRS|Kyverna Therapeutics, Inc (KYTX) - Qarzning sof aktivlarga nisbati|TLSA (Tiziana Life Sciences) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar CABA|Ventyx Biosciences, Inc. (VTYX) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati THTX (Theratechnologies, Inc.)|Avalo Therapeutics Inc. - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Eledon Pharmaceuticals, Inc ELDN|Agenus - Balans kapitallashuviga qarzlar|climbbio.com (CLYM) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati Zura Bio Limited ZURA|Adagene Inc. (ADAG) - Qarzning sof aktivlarga nisbati|IMA: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar STTK|Qarzning balans kapitallashuviga nisbati Equillium, Inc. EQ|Qarzning balans qiymatiga nisbati connectbiopharm.com (CNTB)|Immunic - Balans kapitallashuviga qarzlar|ATRA - Qarzning balans qiymatiga nisbati|Qarzning balans qiymatiga nisbati IFRX (InflaRx GmbH)|XFOR - Sof aktivlarga qarzlar|ACET: Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Celularity|INmune Bio (INMB) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitaliga nisbati Barinthus Biotherapeutics PLC (BRNS)|Kezar Life Sciences, Inc - Qarzning balans qiymatiga nisbati|Balans qiymatiga qarzlar SABS (SAB Biotherapeutics Inc)|Qarzning balans kapitallashuviga nisbati Akari Therapeutics|Enlivex Therapeutics Ltd - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Q32 Bio Corp|GOVX - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar Edesa EDSA|iBio Corporation (IBIO) - Qarzning sof aktivlarga nisbati|CARM (Carisma Therapeutics Inc) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar XTLB|Bolt Biotherapeutics (BOLT) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati HCWB (hcwbiologics.com)|Aptevo Therapeutics Inc. - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati AIM ImmunoTech, Inc. AIM|Aditxt Corp - Balans kapitallashuviga qarzlar|gribio.com (GRI) - Balans kapitallashuviga qarzlar|Qarzning balans qiymatiga nisbati XORTX Therapeutics XRTX|Vyome Holdings Inc. (HIND) - Qarzning sof aktivlarga nisbati|REVB: Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar INDP|Qarzning balans kapitallashuviga nisbati SCNI (Scinai Immunotherapeutics)|Qarzning balans qiymatiga nisbati CALI (calcimedica.com)|Affimed N.V. - Qarzning balans kapitallashuviga nisbati|ALLK - Qarzning balans qiymatiga nisbati|HOOKIPA - Qarzning balans qiymatiga nisbati|IGMS: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati iTeos Therapeutics|oceanbiomedical.com (OCEA) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar TCBP (TC BioPharm)|Balans qiymatiga qarzlar Third Harmonic Bio Inc.